Efficient and safe application of a FOLFIRI/bevacizumab combination to a patient with locally advanced rectal cancer and severe chronic renal failure

MeSH terms

• Adult
• Angiogenesis Inhibitors / administration & dosage
• Angiogenesis Inhibitors / adverse effects
• Antibodies, Monoclonal / administration & dosage*
• Antibodies, Monoclonal / adverse effects
• Antibodies, Monoclonal, Humanized
• Antineoplastic Combined Chemotherapy Protocols / administration & dosage*
• Antineoplastic Combined Chemotherapy Protocols / adverse effects
• Bevacizumab
• Camptothecin / administration & dosage
• Camptothecin / adverse effects
• Camptothecin / analogs & derivatives
• Fluorouracil / administration & dosage
• Fluorouracil / adverse effects
• Humans
• Kidney Failure, Chronic / complications*
• Kidney Failure, Chronic / drug therapy
• Leucovorin / administration & dosage
• Leucovorin / adverse effects
• Male
• Rectal Neoplasms / complications*
• Rectal Neoplasms / drug therapy*
• Treatment Outcome